Research article summary (published 29 Sep 2006):

The insulin analog glargine during an unplanned pregnancy.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Cechurová, Daniela (D); Lacigová, Silvie (S); Jankovec, Zdenek (Z); Haladová, Iva (I); Zourek, Michal (M); Krcma, Michal (M); Rusavý, Zdenek (Z); Turek, Jirí (J);

Journal and publication information

Publication Type: Letter; Research Support, Non-U.S. Gov't

Journal: Wiener klinische Wochenschrift (Wien Klin Wochenschr), published in Austria. (Language: eng)

Reference: 2006-Oct; vol 118 (issue 19-20) : pp 619-20

Dates: Created 2006/11/30; Completed 2007/06/29; Revised 2009/09/10;

PMID: 17136338, status: MEDLINE (last retrieval date: 9/10/2009, IMS Date: 10 Sep 2009 00:00:00)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Diabetes Mellitus, Type 1 - blood; drug therapy Drug Therapy, Combination Female Hemoglobin A, Glycosylated - metabolism Humans Hypoglycemic Agents - adverse effects; therapeutic use Infant, Newborn

Infant, Newborn Insulin - adverse effects; analogs & derivatives; therapeutic use Pregnancy Pregnancy Outcome Pregnancy in Diabetics - blood; drug therapy Pregnancy, Unplanned Treatment Outcome

Associated Chemicals: Hemoglobin A, Glycosylated (0) ; Hypoglycemic Agents (0) ; glargine (0) ; insulin aspart (0) ; Insulin (11061-68-0) ; insulin LISPRO (133107-64-9)

Related articles

These are the highest related articles currently in the database:

• [Can insulin humalog be given during pregnancy?] 21 May 2003
• Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. 30 Jul 2008
• Treatment with insulin and its analogs in pregnancies complicated by diabetes. 29 Jun 2007
• [Two consecutive pregnancies in a type 1 diabetic under treatment with insulin Lispro] 23 Apr 2003
• Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. 30 Oct 2001
• Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin. 30 Oct 2004
• Use of insulin glargine during pregnancy in a type 1 diabetic woman. 30 May 2002
• Pregnant women with type 1 diabetes mellitus treated by glargine insulin. 30 Mar 2006
• Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). 30 Dec 2002
• Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. 30 Oct 2002

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.